Mohamad Khawandanah to Female
                            
                            
                                This is a "connection" page, showing publications Mohamad Khawandanah has written about Female.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.145
         
        
        
     
 
    
        
        - 
            Ibritumomab tiuxetan (Zevalin) and elevated serum human anti-murine antibody (HAMA). Hematol Oncol Stem Cell Ther. 2018 Sep; 11(3):187-188.
            
            
                Score: 0.045
            
         
        
        - 
            Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device. Transfusion. 2015 Mar; 55(3):657-60.
            
            
                Score: 0.036
            
         
        
        - 
            Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2023 05; 23(5):379-384.
            
            
                Score: 0.016
            
         
        
        - 
            Incidence and risk factors for graft failure in the modern era of cord blood transplantation. Vox Sang. 2022 Dec; 117(12):1405-1410.
            
            
                Score: 0.016
            
         
        
        - 
            Embolic stroke of undetermined source in a young woman. Am J Hematol. 2019 09; 94(9):1044-1048.
            
            
                Score: 0.012
            
         
        
        - 
            Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study. Biol Blood Marrow Transplant. 2018 03; 24(3):486-493.
            
            
                Score: 0.011
            
         
        
        - 
            Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera. Ann Hematol. 2015 Apr; 94(4):717-9.
            
            
                Score: 0.009